期刊文献+

重组人Ⅱ型TNF受体-抗体融合蛋白对强直性脊柱炎患者外周血趋化因子受体CXCR4的表达调控作用 被引量:2

下载PDF
导出
摘要 目的探讨强直性脊柱炎(AS)患者T淋巴细胞上趋化因子受体4(CXCR4)表达情况及重组人Ⅱ型肿瘤坏死因子(TNF)受体-抗体融合蛋白(益赛普)对CXCR4在AS中的表达调控作用及其临床意义。方法用流式细胞术分别检测正常对照组、益赛普治疗组,来氟米特和柳氮磺吡啶联合治疗组治疗前后CXCR4表达情况及ESR、CRP表达情况和AS患者疾病活动指数(BASDAI)评分,并对各组结果进行统计学分析。结果AS患者外周血的CD3+CXCR4+表达显著高于正常对照组,益赛普能较来氟米特和柳氮磺吡啶显著地抑制CXCR4表达、降低BASDAI评分,同时也能有效地降低红细胞沉降率(ESR)、C-反应蛋白(CRP)炎症活动性指标,有效地缓解和改善AS病情。结论益赛普不仅能抑制了TNF-TNFR相互作用,同时其可能也通过细胞因子间相互作用抑制T淋巴细胞表达CXCR4,进而抑制CXCR4趋化T淋巴细胞进入关节腔,更有效地改善AS患者病情。
出处 《临床和实验医学杂志》 2008年第11期55-56,共2页 Journal of Clinical and Experimental Medicine
  • 相关文献

参考文献2

二级参考文献33

  • 1Baggiolini M.Chemokines and leukocyte trattic[J].Nature,1998,392(6676):565—566.
  • 2Shadidi KR, Aarvak T, Henriksen JE, et al. The chemokines CCLS, CCL2 and CXCL12 play significant roles in the migration of Thl cells into rheumatoid synovial tissue c[J]. Scand JImmunol, 2003, 57(2): 192-198.
  • 3Crofford L, Tan B, McCarthy C. Hla T involvement of nuclear factor kappa B in the regulation of cyclooxygenase- 2 expression by interleukin - 1 in the rheumatoid synoviocytes [ J ].Arthitis Rheum, 1997, 40(2) : 226 - 236.
  • 4Salmon M, Scheel - Toellner A, Huissoon D, et al. Inhibition of T cell apoptosis in the rheumatoid synovium[J]. J Clin Invest, 1997, 99(3) : 439 - 448.
  • 5Seta N, Gmnfors K, Sahly H, et al. Expression of host defense scavenger receptors in spondyloarthropathy[J]. Arthritis Rheum, 2001, 44(4) :931 - 939.
  • 6Baeten D, Boots A, Steenbakkers, et al. Human cartilage gp - 39 + , Cdl6 + monocytes in peripheral blood and synovium[J]. Arthritis Rhetun, 2000, 43(6): 1233- 1243.
  • 7Kanbe K, Takagishi K, Chen Q. Sfimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell - derived factor 1 and CXC chemokine receptor 4[J]. Arthritis Rheum, 2002, 46(1): 130- 137.
  • 8Nigasawa T, Tachibana K, Kishimoto T. A novel CXC chemokine PBSF/SDF- 1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection[J]. Semin Immunol, 1998. 10(3): 179-lRci.
  • 9Nanki T, Hayashida K, E1- Gabalawy H, et al. Stromal cell- derived factor - 1 CXC chemokine receptor 4 interactionplay a central role in CD4^+ T cell accumulation in rheumatoid arthritis synovium[J]. J Irnmunol, 2000, 165(11): 6590-6598.
  • 10Nanki T, Lipsky P. Cutting edge: Stromal cell derived factor(SDF) - 1 is a co- stimulator for CD4^+ T cell activation[J].J Immunol, 2000, 164(10) : 5010- 5017.

共引文献16

同被引文献21

  • 1古洁若,黄烽,Jatinderpal Kalsi,余得恩.趋化因子受体CXCR4及其配体SDF-1与强直性脊柱炎发病的相关性研究[J].中国病理生理杂志,2005,21(2):224-229. 被引量:17
  • 2冯昭,涂亚庭,曾凡杞.趋化因子SDF-1及其受体CXCR4在皮肌炎皮损中的表达[J].中国皮肤性病学杂志,2005,19(11):654-657. 被引量:6
  • 3张逸彪.类风湿关节炎患者血清和关节液中趋化因子的测定及其意义[J].浙江临床医学,2007,9(10):1349-1349. 被引量:7
  • 4Fairhurst AM. Wandstrat AE. Wakeland EK. et al. Systemic lu?pus erythematosus: multiple immunological phenotypes in a com?plex genetic disease. Adv Immunol. 2006. 92: 61-69.
  • 5Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev. 2000. 177: 175-184.
  • 6Jinquan T. Quan S.Jacobi HH. CXC chemokine receptor 4 expression and stro-mal cell-derived factor-l alpha-induced chemotaxis in CD4 + T lymphocytes are regulated by interleukin-4 and interleukin-lO. Immunology. 2000. 99: 402-404.
  • 7De Page B. SchroderJM. MartinJ J. et al. Localization of the alpho-che-mokine SDF-l and its reception CXCR4 in idiopathic inflammatory myopathies. Neuromascol Disord , 2004. 14: 265- 273.
  • 8Wang A. Guilpain P. Chong BF. et al. Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus. Arthritis Rheum. 2010. 62: 3436-3446.
  • 9Wang A. Fairhurst AM. Tus K. et al. CXCR4/CXCL12 hyperex?pression plays a pivotal role in the pathogenesis of lupus.J Im?munol. 2009. 182: 4448-4458.
  • 10Lian LH. Kee BP. Ng HL. et al. Lack of association between RANTES-28. SDF-l gene polymorphisms and systemic lupus ery?thematosus in the Malaysian population. Genet Mol Res. 2011. 10: 2841-2850 .

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部